KEGG pathway enrichment analysis exhibited that the top 10 pathways (P < 0.05) were the retrograde endogenous cannabinin signaling pathway, complement and coagulation cascade pathway, non-alcoholic fatty liver disease pathway, oxidative phosphorylation pathway, ABC transporter pathway, glycosphingolipid biosynthesis-ganglion series pathway, ECM-receptor interaction pathway, fever pathway, aldosterone synthesis and secretion pathway, and glycosaminoglycan degradation pathway (Figure 6E). This evidence concerns the gene ABCG2 and metabolic dysfunction-associated steatotic liver disease.